Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Colorectal Cancer
Related studies linked through entity extraction aliases.
Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Biological Therapy in Treating Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer
- Status
- COMPLETED
- Phase
- NA
Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan in Treating Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- N/A